Unlocking the Value of Market Research
Participants got a chance to learn from market research professionals on how to effectively target market and set strategic goals using research reports, market segmentation, and competitive analysis.
2018 OBIO Leadership Event at SPiN Toronto
On May 3, OBIO welcomed health science leaders, CEOs and the investment community to the tenth annual OBIO Leadership Event. Hosted at SPiN, the event also saw the launch of Use It or Lose It: Industry Solutions to Ontario's Commercialization Gap, OBIO's 2018 Industry Report. Check out the event photo gallery and recap.
OBIO Hosts: CQDM Non-Dilutive Funding Opportunities from CQDM
Get an in-depth view of the attractive non-dilutive funding programs offered by CQDM which have supported several Ontario health science companies.
✓ Quantum Leap & SynergicQc Programs
✓ Application & Funding Process
✓ Mentorship & Large Pharma Partners
OBIO Speaker Series - Canada’s Innovation Opportunity in a Trump America
OBIO Speaker Series
Canada’s Innovation Opportunity in a Trump America
The first presentation in the OBIO 2017 Speaker Series touched on projections and speculations of the Trump Presidency one month in. Talk topics included the; Affordable Care Act, FDA Policy Changes, Immigration & Talent Acquisition and Big Pharma Pricing
Key Takeaways:
- Trump's victory was based on several key factors including; economic dislocation, capturing the suburbs, mastery over new media and the simplicity of his message
- The rhetoric around the Affordable Care Act has started to shift from “repeal and replace” to “repair” Obamacare as a potential compromise position
- The importance of the FDA Commissioner and how the role will steer the future of that agency, stay on the look out for Dr. Scott Gottlieb the favourite candidate among the biosciences lobby in Washington
- When it comes to international students Canada is already punching above our weight in terms of sheer numbers and there will likely be an increased intertest in Canada as a preferred location
- The impact of Trump's comments have a dramatic affect on the stock market when suggesting major changes as seen when he announced the possiblity of a new bidding procedure for biotech and pharma
- Trump's fiscal policies and its impact on Canada will be seen in Trump’s tax plan and how we modify our own policy priorities to respond to the U.S. agenda
Michael Ras - an observer of politics and the intersection of government policy and business - will look at Trump's campaign, the underlying demographic and social shifts that were responsible for his success and will attempt to predict where his policies might take the U.S. Most importantly, he will examine what a Trump administration means to the Canadian economy and in particular our bioscience industry.
Speaker
Michael Ras - Senior Counsel, HOWE&WYE PR
Michael Ras is a public affairs and strategic communications professional with 20 years of broad experience representing a wide variety of industries at the Federal, Provincial and Local levels of government across Canada. Michael has worked as the Director of Development for the Ivey Centre for Health Innovation and Leadership – a centre dedicated to introducing innovation, higher-levels of leadership and business focus to the Canadian health care system. Michael continues to be engaged on government relations programs for pharmaceutical, biotech and life sciences companies.
Inaugural OBIO® H2BB™ Onboarding Session
OBIO hosted the inaugural H2BB™ Onboarding Session with the first cohort of OBIO Health to Business Bridge™ interns.
OBIO® Pitches and Pitchers!
OBIO hosted its third successful Pitches & Pitchers event, where colleagues and investors in the industry got together to watch each other compete in a two-minute pitch event over pizza and beer!
OBIO CAAP 2017 Launch & Wine & Cheese
OBIO launched the the 2017 OBIO CAAP Program with an information session followed by a very well attended Wine & Cheese networking session. Attendees learned about the exclusive OBIO® CAAP program's benefits and timeline for 2017.
Tools & Tactics for Competitive Analysis & Investor Targeting
The OBIO Team led by OBIO's own VP, Strategic Finance, Christine Charette, hosted a workshop on competitive analysis and investor targeting.
Fed Dev Ontario and OBIO Presenting an Exclusive Biopharma Challenges & Opportunities Roundtable
Fed Dev Ontario and OBIO presented an exclusive Biopharma Challenges & Opportunities Roundtable on Thursday October 20th 1:30pm at The Yonge Richmond Centre in downtown Toronto!
Attracting Angels with Henry Kay, Boston Harbor Angels and Mark Kohler, Exelerate Capital
OBIO hosted Henry Kay of Boston Harbor Angels & Mark Kohler of Exelerate Capital for an insightful workshop on types of angel investors representing both sides of the border with industry experience in all of the health science sub-sectors.
Value Your Venture with James Rowland, Bloom Burton
OBIO hosted James Rowland of Bloom Burton & Co. at a well attended workshop on the hot topic of Valuation.
OBIO® Pitches & Pitchers!
OBIO hosted its second successful Pitches & Pitchers event, where colleagues in the industry got together to watch each other compete in a two-minute pitch event over pizza and beer!
NeuroTech Ontario Showcase & Talk
OBIO CAAP and Pre-CAAP Companies were out in full force at the Ontario Brain Institute's NeuroTech Ontario Showcase + Public Talk.
Learn More About the Event Here:
http://www.braininstitute.ca/event/neurotech-ontario-showcase-public-talk
Market & Competitive Analysis, With Virtus Insights
Cornering the Market with Virtus Insights!
OBIO invited expert business coaches and experienced entrepreneurs Nick Kuryluk and Sue Elliott of Virtus Insights to examine critical Market and Competitive Analysis.
The highlight of the discussion centred on understanding the key influencers on the buying process. A fitting theme during Global Biotech Week!
OBIO® Presents... Bill Charnetski, Ontario's Chief Health Innovation Strategist and the Health Technologies Fund
Want to learn more about the Health Technologies Fund, what it can do for you and how to apply?
Join OBIO in partnership with the Office of the Chief Health Innovation Strategist and Ontario Centres of Excellence for an exclusive HTF Webinar.
OBIO® Executive Exchange Series: Privacy Exposed!
OBIO® Executive Exchange Series: Privacy Exposed!
Preventing Privacy Problems and Providing Solutions for Digital Health and
All Health Science Businesses
With Brendan Seaton, Patrick Lo and Mark Kohler from Privacy Horizon Inc.
Click here to register - Join us and ask your questions!
NRC Interactive Simulations – Soaring to New Heights in Healthcare Delivery with Robert DiRaddo
May 11, 2016 NRC Interactive Simulations – Soaring to New Heights in Healthcare Delivery with Robert DiRaddo
OBIO® Executive Exchange Series: Be Nimble, Be BOLD
OBIO® EXECUTIVE EXCHANGE SERIES: BE NIMBLE, BE BOLD
May 4, 2016 Key Lessons on Building a Life Science Company: Raising capital and more with Neil Klompas, CFO of Zymeworks.
OBIO® Pre-CAAP Workshop 3: Early-Stage Health Science Company Contracts
April 19, 2016 Early-Stage Health Science Company Contracts, with Owen Roberts (Nobelex), & Chad Bayne (Osler).
OBIO® Executive Exchange Series: Creating Your Winning Go-to-Market Strategy – Learn from the Locemia Experience with Claude Piché and Martin Lafontaine
Apr. 15, 2016 Creating Your Winning Go-to-Market Strategy – Learn from the Locemia Experience with Claude Piché and Martin Lafontaine
OBIO® Pre-CAAP Workshop 2: Social Media and Branding Strategies for Health Science Companies
March 30, 2016 Social Media and Branding Strategies for Health Science Companies, with Lorelei Graham, Norton Rose Fullbright.
OBIO® Executive Exchange Series: Due Diligence for Deal Making – Perspectives from Both Sides of the Table with Ela Borenstein and Ihor Boszko
March 22nd, 2016 8:30-10:00AM OBIO invites you to join us for this exceptional members-only opportunity to learn from Ela Borenstein, Managing Partner, BDC Capital Healthcare Venture Fund and Ihor Boszko, Vice President, Business Development, Xagenic on how to prepare for the due diligence process to successfully close your financing!
Closing the Deal with Tech Transfer Offices - Build your Health Technology Company
Mar 2, 2016 OBIO invites you to join us for the first in a series of unique Pre-CAAP workshops throughout 2016 designed for companies that are in the process of raising or will have raised “seed” or later rounds of financing by the end of 2016 and may apply for the next cycle of OBIO CAAP.
Ready, Set, Raise! - with Kelly Holman
Feb 26, 2016 8:30-10 AM Ready, Set, Raise! - With Kelly Holman, Co-Founder and Managing Director Genesys Capital. Click here to register and here for more information.
• OBIO invites you to join us for this unique opportunity to hear from Kelly Holman, Co-founder and Managing Director of Genesys Capital, and one of Canada’s most experienced life science venture capitalists.
• In a Q&A format, Kelly will provide his valuable insights on the financing landscape for health technology companies and the essentials of raising capital.
Pre-CAAP® Webinar
OBIO will hold an information session on Pre-CAAP by webinar February 1st, 2016 at 12 noon. Click here to register and obtain login details.
OBIO Open House
Please join us for OBIO’s Holiday Open House this Friday December 11th, from 3pm to 6pm.
OBIO Pre-CAAP Workshop 7: Investor Pitch
Dec. 1, 2015 Peter Adams will give participants a practical approach to getting your value across in a Pitching to Investors scenario. Click here to register (OBIO members only)
OBIO Pre-CAAP Workshop 6: Build Your Bioscience Financial Model
Nov. 17, 2015 Jamie Stiff of Genesys Capital will demonstrate ways to model your company's financial and revenue plans to convince investors to invest. Click here to register (OBIO members only)
OBIO CAAP® Information Session
Initiated in 2013, the OBIO Capital Access Advisory Program operates downstream from other programs and targets the critical issue of access to capital at the Series A to later stages of venture financing. For more information, click here